 BioNTech SE BNTX, 6.24 said Monday it had net income of 1.784 billion euros, or EUR6.98 a share, in the third quarter, down from EUR6.087 billion, or EUR12.35 a share, in the year-earlier period. Revenue fell to EUR3.461 billion from EUR6.087 billion a year ago. 